2022
DOI: 10.3389/fneur.2022.865307
|View full text |Cite
|
Sign up to set email alerts
|

Insidious Attentional Deficits in Patients With Cerebral Small Vessel Disease Revealed by Attention Network Test

Abstract: BackgroundSeveral reports have indicated potential cognitive decline for cerebral small vessel disease (CSVD), especially in attention domain, whereas the attentional function at network level is still elusive. In this study, we used the attention network test (ANT) paradigm to characterize the efficiency of the alerting, orienting, and executive control networks in patients with CSVD and explore possible correlations between attention network efficiencies and obtained CSVD total score.MethodsA total of 31 pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…Then, we may encourage the use of computerized and easy-to-follow procedures to assess attention, instead using exclusively traditional pencil-and-paper tests. Because of the very simple instructions, the Attention Network Test [38] is an open-source instrument that can be easily used across different age groups, educational levels, and pathological conditions [52][53][54][55]. Nonetheless, normative standardized data about this test should be necessary for its adoption also in clinical contexts.…”
Section: Discussionmentioning
confidence: 99%
“…Then, we may encourage the use of computerized and easy-to-follow procedures to assess attention, instead using exclusively traditional pencil-and-paper tests. Because of the very simple instructions, the Attention Network Test [38] is an open-source instrument that can be easily used across different age groups, educational levels, and pathological conditions [52][53][54][55]. Nonetheless, normative standardized data about this test should be necessary for its adoption also in clinical contexts.…”
Section: Discussionmentioning
confidence: 99%
“…This study excluded the following patients: (1) with a history of recent (within 6 months) or multiple strokes; (2) comorbid with other neurological diseases such as epilepsy, Parkinson’s disease and multiple sclerosis; (3) systemic diseases that may affect cognition, such as tumors and hypothyroidism; (4) head trauma or hemorrhage; (5) mental illness such as moderate to severe anxiety and depression; (6) drug or alcohol abuse; (7) visual or hearing impairment; and (8) unable to cooperate with MRI examination (Guo et al, 2022 ).…”
Section: Methodsmentioning
confidence: 99%